2019冠狀病毒

港大及中大醫學院聯合研究發現已接種疫苗人士在感染新型冠狀病毒變異株Omicron後能對不同的新冠病毒變異株 產生更強烈和更廣泛的中和病毒抗體反應. (n.d.). Retrieved June 13, 2022, fromhttps://sph.hku.hk/zh-HK/News-And-Events/Press-Releases/2022/HKUMed-CU-Medicine-joint-study-shows-that-vaccinated-individuals-develop-more-robust

World Health Organization. (n.d.). Episode #64 - why are experts concerned about Omicron? World Health Organization. Retrieved June 13, 2022, fromhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-64---why-are-experts-concerned-about-omicron?gclid=CjwKCAjwnZaVBhA6EiwAVVyv9KWbT5unxR-eASZfaRh3YDubSzpAKJyreEwDA1CP-2n_XWFlKb67sxoCbqEQAvD_BwE

World Health Organization. (n.d.). Coronavirus. World Health Organization. Retrieved June 13, 2022, fromhttps://www.who.int/health-topics/coronavirus#tab=tab_3

Centre for Health Protection, Department of Health. (2022, April 8). 2019冠狀病毒防疫錦囊. Retrieved June 13, 2022, fromhttps://www.coronavirus.gov.hk/pdf/tips_booklet.pdf

Ferguson NM, Laydon D, Nedjati-Gilani G, et al, on behalf of the Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand.https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf

Mahase, E. (2021). Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ.https://doi.org/10.1136/bmj.n2713

2019冠狀病毒病第5波數據 Statistics on 5th Wave of COVID-19. (n.d.). Retrieved June 13, 2022, fromhttps://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf

曾德賢醫生 (n.d.). 新冠口服藥大減死亡風險 醫管局庫存充足 應付下一波疫情. Retrieved June 13, 2022, fromhttps://www.ha.org.hk/haho/ho/pad/266898tc.pdf